Recent News

• 12.09.2025 - Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
• 11.14.2025 - Teleflex to Present at the Jefferies Global Healthcare Conference in London
• 11.06.2025 - Teleflex Announces Quarterly Dividend
• 11.06.2025 - Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
• 10.16.2025 - Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
• 09.11.2025 - First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
• 08.26.2025 - Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.19.2025 - Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Recent Filings

• 12.09.2025 - 8-K Current report
• 12.09.2025 - EX-99.1 EX-99.1
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.06.2025 - 8-K Current report
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - EX-99.1 EX-99.1
• 10.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - 4 Statement of changes in beneficial ownership of securities